In recent years, an increasing number of studies have reported that activating the ERK1/2 signaling pathway plays a protective role in MI, myocardial ischemia-reperfusion injury and diabetic heart disease [18,21,22]. The gene discussed is MAPK3; the disease is myocardial infarction.